baber/WOPTO huggingface dataset:
Patent GR-3003882-T3 (GR)
IPC: B63C11/46
Filed: 1992-02-25
Abstract: PCT No. PCT/EP88/00729 Sec. 371 Date Jun. 19, 1989 Sec. 102(e) Date Jun. 19, 1989 PCT Filed Aug. 16, 1988 PCT Pub. No. WO89/02391 PCT Pub. Date Mar. 23, 1989.The appliance for assisting a swimmer in swimming, floating and being towed by a boat, includes a substantially board-shaped floating body having a leading edge and a trailing edge each of which have a V-shaped cross section. The floating body has a glass panel with a transverse reinforcing web mounted centrally therein so that the swimmer can observe through the floating body. The floating body has two longitudinal sides each having a handle in the shape of an arcuate protrusion projecting therefrom. Each of the handles is located in the middle of its longitudinal side, and the longitudinal sides are divided by a central transverse axis, each of the handles having a through-going handle opening positioned between the transverse axis and the leading edge. Fastening means, such as screws, are provided on each handle and a tow rope is attached to each of the fastening means by one of its two ends. The middle portion of the rope is attachable to the boat, preferably by a trailing rope from the boat, so that the swimmer may be towed by the boat while executing lateral gliding motions or diving below the water's surface.
Patent GR-3003912-T3 (GR)
IPC: H04L12/28
Filed: 1992-02-27
Abstract: A communications network comprises a plurality of stations which can communicate via a ring. Information is transmitted from one station to another in message blocks which circulate around the ring. The message blocks include control bits and a protocol is employed which ensures that no one station can monopolise the available message blocks. At any of the stations, an emptying block is utilised by that station as a reallocation trial slot and places its own address therein for passage round the ring. On its return a system reset is instigated to allow all stations to be reallocated "d" blocks.
Patent GR-3005736-T3 (GR)
IPC: A23K1/18
Filed: 1992-09-17
Abstract: The present invention relates to a new method for increasing the productivity of sows. In the method according to the invention, Bacillus IP 5832 and/or its spores is/are administered orally to breeding sows.
Patent GR-3015377-T3 (GR)
Title: Two-step chemical/electrochemical process for coating magnesium.
Inventor: BARTAK DUANE E
IPC: C25D11/30
Filed: 1995-03-13
Abstract: A two-step process for coating magnesium and its alloys is disclosed. The first step comprises immersing the magnesium in an aqueous solution comprising about 0.2 to 5 molar ammonium fluoride at a temperature of about 40 to 100  DEG C. The second step is an electrochemical treatment in an aqueous electrolytic solution having a pH of at least about 12.5 and which solution comprises about 2 to 12 g/L of a soluble hydroxide, about 2 to 15 g/L of a fluoride-containing composition, and about 5 to 30 g/L of an alkali metal silicate.
Patent GR-3015228-T3 (GR)
Title: 2,3-Dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments.
Inventor: EFFLAND RICHARD CHARLES DR
IPC: C07D409/14
Filed: 1995-02-28
Abstract: This invention relates to 2,3-dihydro-1-(pyridinylamino)-indoles of the formula <CHEM> wherein R1 is hydrogen, loweralkyl, aryl, arylloweralkyl, alkenyl, alkynyl or heteroarylloweralkyl selected from the group consisting of pyridinylmethyl, pyridinylethyl, thienylmethyl, thienylethyl; R2 and R3 are independently hydrogen, loweralkyl, aryl, arylloweralkyl or heteroarylloweralkyl selected from the group consisting of pyridinylmethyl, pyridinylethyl, thienylmethyl, thienylethyl; or R2 and R3 together form a cycloalkane ring of 4 to 6 carbons or a spiro-fused aryl or heteroaryl cycloalkane; X and Y are independently hydrogen, halogen, hydroxy, loweralkyl, loweralkoxy, nitro, amino or trifluoromethyl; m and n are independently integers of 1 to 3, the pharmaceutically acceptable acid addition salts thereof and where appropriate, the optical, geometrical and stereoisomers and racemic mixtures thereof. The compounds of this invention are useful as analgesics, anticonvulsants, for enhancing memory and for the treatment of Alzheimer's disease.
Patent GR-3019815-T3 (GR)
Title: Laundry composition containing peroxyacid bleach and soil release agent
Inventor: CLAUSS ALLEN DAVID
IPC: D06L3/02
Filed: 1996-05-02
Abstract: The present invention relates to laundry cleaning compositions and methods comprising a peroxyacid bleach and a soil release agent.
Patent GR-3020154-T3 (GR)
Title: Sloping roof provided with roofing tiles and til hook to be used for a roof of this type
Inventor: BOGAERTS ALBERT FELIX JOSEPH
IPC: E04D1/34
Filed: 1996-06-06
Abstract: PCT No. PCT/NL93/00074 Sec. 371 Date Sep. 21, 1994 Sec. 102(e) Date Sep. 21, 1994 PCT Filed Mar. 26, 1993 PCT Pub. No. WO93/20304 PCT Pub. Date Oct. 14, 1993.The roof tiles (1) of a sloping roof rest via a ridge on tile laths (2) and overlap one another in two directions. They are fixed with tile hooks (4) and each tile hook (4) comprises a first shaft section (7), which at the free end has a hook-shaped bend (8) which grips around a closing groove (6) on a side edge of a first tile, a second shaft section (9), which at the free end has a device (10) by which the tile hook is fixed to a tile lath (2), and a shoulder (11), which is located between the two shaft sections (7 and 9) and engages on the rear surface of a second tile partially located under the first tile. The two shaft sections (7 and 9) of the tile hooks are essentially perpendicular to the shoulder (11).
Patent GR-3020087-T3 (GR)
Title: Process for preparing a filter unit and the filter unit prepared by said process
Inventor: DOMME ALOIS
IPC: B01D39/16
Filed: 1996-05-30
Abstract: The production process for a filter unit (10) in the form of an adsorptive moulding (8') provides that granules of an adsorbent, in particular activated charcoal, and a granular thermoplastic organic binder are mixed dry. The dry mixture is then placed in a mould and compressed in this. With substantial prevention of supply of air, the mixture in the mould is heated to a temperature essentially above the plastic region of the binder. The temperature is maintained until charring and at least partial carbonisation of the binder occurs. The moulding is then cooled and removed from the mould. A filter unit thus produced having an inlet side (3) and outlet side (5) for the filtrate is characterised in that in the adsorbent (8') the granules of the adsorbent are fixed in the residual structure of the charred and partly carbonised in an open-pored manner, organic binder having micropores. The adsorption body (8') can be held between an inlet-side (4) and an outlet-side (6) porous support wall, these walls joining flush to the body (8'). The support walls can be fabricated as sintered bodies and can act as a mechanical fine filter. <IMAGE>
Patent GR-3023458-T3 (GR)
Title: Family of porphin ring substances, method of obtaining them from cyanophyceae, and applications as cosmetics and as therapeutic products.
Inventor: PEPIN DENISE
IPC: C12P17/18
Filed: 1997-05-16
Abstract: Family of porphin ring substances, method of obtaining them from chlorophyllous plants, particularly cyanophyceae, and applications as a cosmetic, particularly against the effects of natural ageing of the skin, and as a therapeutic product in certain skin diseases (acne rosacea, inflammation, scaring of the skin).
Patent GR-3025022-T3 (GR)
Title: 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
Inventor: CHANDRAKUMAR NIZAL SAMUEL
IPC: A61P43/00
Filed: 1997-10-14
Abstract: The present invention provides substituted dibenzoxazepine compounds of Formula I:    <IMAGE>  Formula I  wherein X is oxygen, sulfur   <IMAGE>   A is -CH2- or   <IMAGE>   E and F may be -CH, oxygen, nitrogen or sulfur, and may not be the same; G is oxygen, nitrogen or sulfur; with the proviso that when G is oxygen or sulfur, one of E or F is nitrogen, which are useful as analgesic agents for the treatment of pain, and as prostaglandin-E2 antagonists for the treatment of prostaglandin-E2 mediated diseases, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, a method for eliminating or ameliorating pain in an animal, and a method for treating prostaglandin-E2 mediated diseases in an animal, comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.
Patent GR-3026697-T3 (GR)
Title: Imide derivatives, and their production and use
Inventor: SAJI IKUTARO
IPC: C07D275/06
Filed: 1998-04-23
Abstract: An imide compound of the formula: <CHEM>  wherein     Z is a group of the formula: <CHEM> in which B is a carbonyl group or a sulfonyl group, R<1>, R<2>, R<3> and R<4> are each a hydrogen atom or a lower alkyl group, or R<1> and R<2> or R<1> and R<3> may be combined together to make a non-aromatic hydrocarbon ring or R<1> and R<3> may be combined together to make an aromatic ring, said non-aromatic hydrocarbon ring being optionally bridged with a lower alkylene group or an oxygen atom therein and said aromatic ring, said non-aromatic hydrocarbon ring and said lower alkylene group being each optionally substituted with at least one lower alkyl, and n is an integer of 0 or 1;     D is a group of the formula:    -(CH2)p-A-(CH2)q-   in which A is a non-aromatic hydrocarbon ring optionally bridged with a lower alkylene group or an oxygen atom, said non-aromatic hydrocarbon ring and said lower alkylene group being each optionally substituted with at least one lower alkyl, and p and q are each an integer of 0, 1 or 2; and Ar is an aromatic group, a heterocyclic aromatic group, a benzoyl group, a phenoxy group or a phenylthio group and G is <CHEM>  or Ar is a biphenylmethylidene group and G is <CHEM> all of the above groups being each optionally substituted with at least one of lower alkyl, lower alkoxy and halogen; and its acid addition salts, useful as an antipsycotic agent.
Patent GR-3030221-T3 (GR)
Title: Electric motor
Inventor: PSZOLA PETER
IPC: H02K9/26
Filed: 1999-05-13
Abstract: An air stream, in particular for cooling, may be applied to an electric motor (3), in particular a universal motor. A movable, preferably rotary flow guiding part is arranged in a flowpath of the air stream. The air stream passes through at least part of the flow guiding part and is deflected within the flow guiding part. A pocket (10) is designed for receiving the deflected air stream. In order to effectively filter out the finest particles, in particular coal dust particles, with as simple a design as possible, one wall (11) of the pocket may be moved together with the flow guiding path at substantially the same (angular) speed. The flow guiding path is arranged in the flowpath of the air stream preferably downstream of the moving parts of the electric motor.
Patent GR-3030499-T3 (GR)
Title: Ergometric device
Inventor: TKATCHOUK ELENA N
IPC: A61B5/22
Filed: 1999-06-10
Abstract: Apparatus for producing a hypoxic gas mixture having a higher nitrogen-to-oxygen ratio than atmospheric air has a diaphragm compressor feeding air under pressure to an oxygen-depleting unit having a perforate tube extending axially of a cylindrical chamber having an outlet in one side. The annular space between the perforate tube and the wall of the chamber is filled with axially extending hollow fibers of poly-4-methyl-penthene-1. Ends of the chamber are closed except for the interiors of the hollow fibers which are open to the atmosphere. The walls of the hollow fibers are more permeable to oxygen than to nitrogen so that part of the oxygen escapes through open ends of the hollow fibers, thereby increasing the nitrogen-to-oxygen content of the gas.
Patent GR-3031448-T3 (GR)
Title: Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine.
Inventor: RUDNIC EDWARD M
IPC: A61K9/20
Filed: 1999-10-07
Abstract: The present invention relates to a composition and method of treating a patient by administering carbamazepine in a pharmaceutical dosage form capable of maintaining the patient's blood concentration at from about 4  mu g/ml to about 12  mu g/ml over at least a 12 hour period, where the blood concentration of carbamazepine does not vary by more than 60 percent.
Patent TR-200301649-T3 (TR)
Inventor: VINCENT NATHALIE
IPC: C02F1/44
Filed: 2001-12-04
Abstract: The invention concerns a method for avoiding irreversible membrane clogging while maximising productivity, whatever the quality of the fluid at the installation intake. It consists in automatically controlling the installation operating parameters by performances induced by the quality of the fluid to be treated, based on predictions concerning the evolution of the membrane clogging carried out by modelling with a neuron network so as to simulate the long term operating conditions of the membrane filtering installation, the model enabling, on the basis of the quality of the in-flowing fluid and on the state of the membranes during a given cycle, to calculate the evolution of the clogging state of said membranes on a time basis, on a specific horizon, said calculation being performed for a simulated in-flowing quality, constant or variable, on said horizon (H) and to control and adjust the installation operating parameters.
Patent TR-200502558-T3 (TR)
Title: Filamanlardan, viril bağlı örme olmayan bir kumaş yapma prosesi
Inventor: SOMMER SEBASTIAN
IPC: D04H3/11
Filed: 2003-02-10
Abstract: Termoplastik filamanlardan örme olmayan bir iplik yapma prosesinde, gruplanmış gevşek fılamanlar, bir ıslatıcı madde ile işleme tabi tutulmakta ve daha sonra hidrodinamik hareket ile entegre hale getirilir ve güçlendirilir. Filamanlar, bir iplik eğirici ile oluşturulur, soğutulur ve bir emme cihazı üzerinden hareket eden hareketli bir elek elyaf yakalama kayışı üzerine bağımsız gevşek halde boşaltılır. Elyafların bir araya toplanmış gevşek tomar hali, bir su püskürtme motorunun takip ettiği, bir tensio-aktif madde ile ıslatıldıkları bir ıslatma istasyonuna doğru kayış üzerinde ilerlerler.
Patent GR-3035391-T3 (GR)
Title: Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein.
Inventor: MERTENS KOENRAAD
IPC: C07K14/745
Filed: 2001-02-07
Abstract: A method for the generation of Ca++ independent antibodies against blood coagulation factors is described wherein an antibody selection strategy based upon small peptides comprising target sequences for limited proteolysis is employed. These antibodies which distinguish between intact and cleaved species of haemostatic protein provide novel tools for the isolation of intact haemostatic proteins.
Patent GR-3035752-T3 (GR)
Title: Process for the preparation of galanthamine and its derivatives
Inventor: BANNISTER ROBIN MARK
IPC: A61K36/896
Filed: 2001-04-12
Abstract: The subject invention pertains to a process for preparing a compound having a formula (4) or (5), in either optically-enriched or racemic form, wherein R1, R2, R3 and R4 are independently selected from hydrogen, alkyl, aryl, alkaryl, aralkyl and acyl groups. In one embodiment, the process of the invention comprises mixing with a plant extract obtained from crushed daffodil bulbs or crushed snowdrop bulbs an oxidative cyclisation precursor of the compound.
Patent GR-3036884-T3 (GR)
Title: Liquid ophthalmic sustained release delivery system
Inventor: YEN SHAU-FONG
IPC: A61K47/36
Filed: 2001-10-16
Abstract: Disclosed is a sustained release liquid aqueous ophthalmic delivery system and a method of providing a slow and sustained release of ophthalmic treating agents to the eye of a mammal which comprises administering to the eye of a said mammal an effective amount of a homogeneous liquid aqueous ophthalmic pharmaceutical composition, of pH between about 3.0 and about 6.2, which is adminstrable in drop form and which comprises an ophthalmically effective concentration of a said ophthalmic treating agent and about 0.05% to about 10% by weight of the polymer chitosan; said polymer consisting essentially of (A) monomeric  beta (1->4)-D-glucosamine linked units and of (B) monomeric  beta (1->4)-D-glucosamine linked units which are scattered randomly in the molecule of the polymer, the numerical proportions of A and B being from about 60 to about 99% of A and about 1 to about 40% of B, the viscosity rating being from about 3 to about 3000 cps; in which method, upon contact with the higher pH of the ocular fluid, said liquid formulation is converted to a stiff gel from which the ophthalmic treating agent is slowly released over a prolonged period of time.
Patent GR-3037092-T3 (GR)
Title: Tyrosinase-activator protein fusion enzyme
Inventor: DELLA-CIOPPA GUY
IPC: C12N15/86
Filed: 2001-10-31
Abstract: The present invention relates to a nucleic acid sequence that encodes a fusion enzyme of tyrosinase and a tyrosinase activator protein. Further, the present invention also relates to the amino acid sequence which is encoded by the nucleic acid sequence of the fusion enzyme. The fusion enzyme may also include a linker positioned between the amino acid sequences of the tyrosinase and the tyrosinase activator protein. Still further, the present invention also relates to a vector useful for introducing the nucleic acid sequence encoding the fusion enzyme into an organism. Still further, the present invention relates to melanins made by the fusion enzyme and a method for making melanins using the fusion enzyme.
Patent DK-1212081-T4 (DK)
Inventor: GERSTEIN HERTZEL
IPC: A61K31/403
Filed: 2000-08-25
Granted: 2014-07-07
Abstract: Novel use of an inhibitor of the renin-angiotensin system or derivative (I) in the manufacture of a medicament for the prevention of stroke in patients exhibiting normal or low blood pressure, diabetes and/ or congestive heart failure (CHF) with no pre-existing CHF. Independent claims are also included for: a method of preventing of stroke in patients exhibiting normal or low blood pressure, diabetes and/ or congestive heart failure (CHF) with no pre-existing CHF; and a formulation for use in the prevention of stroke in patients exhibiting normal or low blood pressure, diabetes and/ or congestive heart failure (CHF) with no pre-existing CHF. ACTIVITY : Cerebroprotective; Cardiant; Antidiabetic. Treating 9,541 patients who are at risk for cardiovascular events due to a history of previous ischemic heart disease, stroke, peripheral arterial disease or individuals with diabetes with ramipril for 6 years resulted in a 32% reduction in the number of patients who developed a stroke, 21% who developed congestive heart failure, and 36% reduction who developed diabetes. MECHANISM OF ACTION : Angiotensin converting enzyme (ACE) inhibitor; an angiotensin II antagonist.
Patent DK-1312385-T4 (DK)
Inventor: M COLLIN REMI
IPC: A61M25/00
Filed: 2002-11-19
Granted: 2010-01-18
Abstract: In an intraluminal medical device having (at least locally) a hydrophilic zone (HZ) of first hydrophilic material (HM1) showing a low coefficient of friction when treated with a wetting agent (WA) before use of the device, HZ in the dry state includes a second hydrophilic material (HM2) for retaining WA in HZ, reducing evaporation of WA into the atmosphere and/or preventing WA from flowing (like water) in the treated zone. <??>Independent claims are included for: <??>(1) a combination of a device as above (specifically a probe) and a casing in which the wetted, impregnated device is stored; and <??>(2) a method for preparing the device in the casing, including formation of the HZ including HM2 (as well as HM1) and sterilization with gas via a gas-permeable wall of the casing.
Patent TR-201802343-T4 (TR)
Title: Evsel polimer atıklardan yüksek yoğunluklu polietilen geri kazanımı.
Inventor: LAURENT DURANEL
IPC: B29B17/02
Filed: 2012-04-05
Abstract: EVSEL POLİMER ATIKLARDAN YÜKSEK YOĞUNLUKLU POLİETİLEN GERİ KAZANIMI Mevcut uygulama çok iyi mekanik özelliklere sahip bir polietilen karışımı elde etmek için evsel polimer atığından yüksek yoğunluklu polietilen atığı elde etmek için bir yöntemle ilgilidir. Mevcut uygulama bu tür polietilen karışımlarıyla ilgili olduğu kadar bahsedilen polietilen karışımını içeren nesnelerle de ilgilidir.
Patent TR-201807503-T4 (TR)
Title: Geniş görüşlü nokta nişan alma cihazı.
Inventor: DONG HEE LEE
IPC: G02B27/30
Filed: 2008-07-03
Abstract: Paralaksın en aza indirilmesi sayesinde nişan almanın hızlı ve isabetli bir şekilde gerçekleştirilebildiği dürbünle görmeye yönelik yüksek kalibreli bir nokta nişan alma cihazı sağlanmaktadır. Nokta nişan alma cihazı, ağır makineli bir silah için bir desteğe bağlanmaktadır ve destekten ayrılmaktadır. Ayrıca, yüksek kalibreli nokta nişan alma cihazının kullanılması vasıtasıyla, bir kullanıcı, hedefin türlerini ve özelliklerini ve hedefe olan mesafeyi göz önünde bulundurarak hızlı ve isabetli bir şekilde bir hedefe nişan alabilmektedir ve hedefi ateşleyebilmektedir.
Patent TR-201911128-T4 (TR)
Title: Neısserıa menıngıtıdıs fhbp varyantı ve bunun aşılamaya yönelik kullanımı.
Inventor: CHRISTOPH TANG
IPC: C12N15/00
Filed: 2013-08-22
Abstract: Buluş, bir yabani tür V2 fHbp üzerinden artmış stabiliteye sahip bir modifiye edilmiş V2 fHbp; SEKANS KİMLİK NUMARASI: 1'in sekansına en az %85 özdeşliğe sahip bir amino asit sekansına sahip bir modifiye edilmiş V2 fHbp ile ilgilidir, burada hem Ser137 hem de Gly138 mutasyona uğramaktadır veya hem Val112 hem de Leu114 mutasyona uğramaktadır; ayrıca buluş immünojenik, farmasötik ve aşı bileşimleri; nükleik asit ve bir konak hücre ve bu tür bileşimlerin kullanım yöntemleri ile ilgilidir.
Patent DE-10392362-T5 (DE)
Title: Verfahren zur Behandlung von Haaren
Inventor: LATORRE GUY
IPC: A61K8/19
Filed: 2003-03-07
Abstract: Verfahren
zum Behandeln von Haaren, aufweisend das Aufbringen einer bioaktiven
Glaszusammensetzung in einer effektiven, haarverbessernden Menge
auf das Haar über
eine ausreichende Zeitspanne, so dass sich ein Überzug auf dem Haar ausbildet,
der Silizium-, Kalzium-, und/oder Phosphorionen umfasst.
Patent DE-10392368-T5 (DE)
Title: Bestimmung der Position eines Publikumsteilnehmers, der ein tragbares Medienüberwachungsgerät besitzt
Inventor: JENSEN JAMES
IPC: H04N17/00
Filed: 2003-03-05
Abstract: Tragbare
Medienüberwachungseinrichtung
zur Erfassung von Daten, um Reichweitenschätzungen auf der Grundlage von
akustischer Energie zu erstellen, die von einer Medienempfangseinrichtung
emittiert wird, wobei die tragbare Medienüberwachungseinrichtung am Körper eines
Publikumsteilnehmers tragbar ist, wobei die tragbare Medienüberwachungseinrichtung
umfaßt:   ein
Schallwandlermittel zur Erzeugung von Wandlerausgabedaten als Antwort
auf empfangene akustische Energie, die akustische Energie von einer
Medienempfangseinrichtung enthält;  ein
Publikummeßcodedetektormittel
zur Detektion von Publikummeßcodes,
die von der Medienempfangseinrichtung akustisch emittiert werden,
auf der Grundlage der Wandlerausgabedaten, um Daten über detektierte
Publikummeßcodes
zu erzeugen;  ein Postionscodedetektormittel zur Detektion eines
ersten Positionscodes, der in einem im voraus festgelegten Gebiet drahtlos
gesendet wird, in dem sich die Medienempfangseinrichtung befindet,
um Daten über
detektierte erste Positionscodes zu erzeugen; und ein erstes Übertragungsmittel zur Übertragung
der Daten über
detektierte Publikummeßcodes
und der Daten über
detektierte erste Positionscodes an ein System zur Erstellung von
Reichweitenschätzungen zur
Erstellung von Reichweitenschätzdaten
auf der Grundlage der Daten...